abstract |
The present disclosure relates generally to compositions for enhancing an immune response in an antigen presenting cell of the immune system via an inhibitor of CD1 signaling. Uses thereof in a therapeutic protocol for treating or preventing conditions associated with a defective or inadequate immune response, such as cancer and infection, are detailed. |